Please assess the completion status of the following clinical trial:

Trial Title: Evaluating Anatomic Versus Targeted Lead Placement for Burst Stimulation Therapy During the Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Patient indicated for Spinal Cord Stimulation therapy in accordance with the approved labeling.~2. Patient's pain profile indicates appropriate lead placement would be at one or more levels from T7 to T10, to achieve pain coverage.~3. Patient has a baseline score on the Numerical Rating Scale ≥6 over the past 24 hours for 'average overall pain'specific to the area(s) of chronic pain that will be treated with spinal cord stimulation.~4. Patient is considered by the Study Investigator as a candidate for implantation of a spinal cord stimulator system according to the system Instructions for Use.~5. Patient is \>18 years of age at the time of enrollment.~6. Patient is willing to adhere to the study requirements, including compliance with and completion of all study visits.~7. Patient has signed and received a copy of the Ethical Committee/Independent Review Board approved informed consent.~Exclusion Criteria:~1. Patient currently has a spinal cord stimulation system implanted.~2. Patient has previously failed a spinal cord stimulation therapy (either trial system evaluation or permanent system implant).~3. Patient has a primary diagnosis of Peripheral Vascular Disease (PVD), Angina Pectoris, or Chronic Migraine.~4. Patient is scheduled to undergo an on-the-table trial evaluation (aka all-in-one procedure)~5. Patient is scheduled to be implanted with (a) surgical paddle trial lead(s).

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Group 1 (AB) (Type: ACTIVE_COMPARATOR): Group 1 (AB): anatomic lead placement followed by BurstDR™ stimulation during an initial trial evaluation period
- Group 2 (TB) (Type: ACTIVE_COMPARATOR): Group 2 (TB): targeted lead placement followed by BurstDR™ stimulation during an initial trial evaluation period

Based on this trial design, predict the completion outcome and termination type (if applicable).